Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19

被引：13
|
作者：
Mendez, Sean R. [1 ]
Frank, Rachel C. [2 ]
Stevenson, Elizabeth K. [5 ]
Chung, Mabel [3 ,4 ,6 ]
Silverman, Michael G. [2 ,4 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Boston, MA USA
[3] Massachusetts Gen Hosp, Crit Care & Pain Med, Dept Anesthesia, Boston, MA USA
[4] Massachusetts Gen Hosp, Heart Ctr Intens Care Unit, Boston, MA USA
[5] North Shore Med Ctr, Crit Care, Div Pulm, Salem, MA USA
[6] Smith Ctr Outcomes Res Cardiol, Div Cardiovascular Med, Dept Med, Beth Israel Deaconess Med Center, Boston, MA USA
来源：
CHEST | 2021年 / 160卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.chest.2021.01.073
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：89 / 93
页数：5
相关论文
共 50 条
  • [21] Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study
    Rouette, Julie
    McDonald, Emily G. G.
    Schuster, Tibor
    Brophy, James M. M.
    Azoulay, Laurent
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (24):
  • [22] Risk factors for severe COVID-19
    Gupta, Harish
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (09) : 2194 - 2195
  • [23] COVID-19: Rare variants increase the risk of severe COVID-19
    van de Veerdonk, Frank L.
    Netea, Mihai G.
    ELIFE, 2021, 10
  • [24] Genetic Risk of Severe Covid-19
    Kaser, Arthur
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (16): : 1590 - 1591
  • [25] An 11-year retrospective comparison of dihydropyridine and non-dihydropyridine calcium channel blockers
    Jang, David H.
    Spyres, Meghan B.
    Nelson, Lewis S.
    Hoffman, Robert S.
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 640 - 640
  • [26] THE INTERACTION OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS WITH CALMODULIN AND CALMODULIN INHIBITORS
    THAYER, SA
    FAIRHURST, AS
    MOLECULAR PHARMACOLOGY, 1983, 24 (01) : 6 - 9
  • [27] Separation of five dihydropyridine calcium channel blockers by micellar electrokinetic chromatography
    Wang, J
    Chen, HF
    Zhao, LF
    CHINESE JOURNAL OF ANALYTICAL CHEMISTRY, 1999, 27 (01) : 82 - 84
  • [28] Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
    Staessen, JA
    Birkenhäger, WH
    Fagard, RH
    EUROPEAN HEART JOURNAL, 2000, 21 (01) : 2 - 7
  • [29] Time course for blood pressure lowering of dihydropyridine calcium channel blockers
    Ghamami, Niousha
    Chiang, Sandy Hsiang Yu
    Dormuth, Colin
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [30] Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers
    Schneeweiss, S
    Soumerai, SB
    Maclure, M
    Dormuth, C
    Walker, AM
    Glynn, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) : 388 - 400
12345